Table I.
Clinical characteristics | Value | % |
---|---|---|
Median age (range), years | 64 (31–90) | |
Median BMI (range) | 32.2 (17.4–81.6) | |
Grade, n | ||
1 | 97 | 18.3 |
2 | 120 | 22.7 |
3 | 312 | 59.0 |
Stage, n | ||
I | 337 | 62.4 |
II | 51 | 9.4 |
III | 123 | 22.8 |
IV | 29 | 5.4 |
Peritoneal cytology, n | ||
Negative | 349 | 86.0 |
Positive | 57 | 14.0 |
Pelvic lymph nodes, n | ||
Negative | 366 | 83.2 |
Positive | 74 | 16.8 |
Para-aortic lymph nodes, n | ||
Negative | 327 | 89.6 |
Positive | 38 | 10.4 |
Histology, n | ||
Endometrioid | 404 | 74.8 |
Mixed serous and endometrioid | 22 | 4.1 |
Serous | 114 | 21.1 |
Myometrial invasion, n | ||
≤50% | 314 | 67.1 |
>50% | 154 | 32.9 |
Status, n | ||
With tumor | 78 | 15.5 |
Tumor-free | 425 | 84.5 |
Residual tumor, n | ||
R0 | 370 | 90.7 |
R1 | 22 | 5.4 |
R2 | 16 | 3.9 |
Surgical approach, n | ||
Minimally invasive | 201 | 38.8 |
Open | 317 | 61.2 |
BMI, body mass index.